Scopus (SJR=0.2, Q3), ISC, CAS, ....

Document Type : Review Article

Authors

1 Department of Pharmacy, Guru Ram Das (PG) Institute of Management and Technology, Dehradun, (Uttarakhand), 248009, India

2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, PO Box 840, Saudi Arabia

Abstract

Phosphodiesterase-IV (PDE- IV) inhibitors which are effective anti-inflammatory agents have forced researchers to find new PDE-IV inhibitors with less adverse effects than conventional anti-inflammatory drugs. Some pyridazinone derivatives reduced inflammation by inhibiting PDE-IV enzyme and acted as anti-inflammatory agents. The new pyridazinone derivatives will be more suitable than the currently developed pyridazinone compounds for future studies and could be developed as more safe anti-inflammatory drugs for humans.

Graphical Abstract

Study of heterocyclic-fused pyridazinone analogues having phosphodiestrase-IV inhibitor activities as anti-inflammatory agents

Keywords

1. Asif M., Singh A., Siddiqui A.A. Med. Chem. Res., 2012, 21: 3336
2. Asif M. Chron. Young Sci.., 2010, 1: 3
3. Asif M. J. Adv. Sci. Res., 2010, 1, 35
4. Asif M., Singh A. Lakshmayya, Chron. Young Sci., 2013, 4: 1
5. Asif M. Mini Rev. Org. Chem., 2013, 10: 113
6. Huang Z., Ducharme Y., Macdonald D., Robichaud A. Curr. Opin. Chem. Biol., 2001, 5: 432
7. Jeon Y.H., Heo Y-S., Kim C.M., Hyun Y-L., Lee T.G., Ro S., Cho J.M. Cell. Mol Life Sci., 2005, 62: 1198
8. Francis S.H., Turko I.V., Corbin J.D. Prog Nucleic Acid Res. Mol Biol., 2001, 65: 1
9. Jacob C., Martin-Chouly C., Lagente V. Therapie. 2002, 57: 163
10. Souness J.E., Aldous D., Sargent C. Immunopharmacol. 2000, 47:127
11. Pieretti S., Dominici L., Di Giannuario A., Cesari N., Dal Piaz V. Life Sci., 2006, 79: 791
12. Teixeira M.M., Gristwood R.W., Cooper N., Hellewell P.G. Trends in Pharmacol Sci., 1997, 18: 164
13. Cunha F.Q., Teixeira M.M., Ferreira S.H. British J. Pharmacol., 1999, 127: 671
14. Dyke H.J., Montana J.G. Expert Opin. Investig. Drugs. 2002, 11: 1
15. Jain K.N., Patil C.S., Singh A., Kulkarni S.K. Brain. Res., 2001, 909: 170
16. Ambriz-Tututi M., Velázquez-Zamora D.A., Urquiza-Marín H., Granados-Soto V. Eur. J. Pharmacol., 2005, 512: 121
17. Mixcoatl-Zecuatl T., Aguirre-Bañuelos P., Granados-Soto V. Eur. J. Pharmacol. 2000, 400: 81
18. Asomoza-Espinosa R., Alonso-Lopez R., Mixcoatl-Zecuatl T., Aguirre- Bañuelos P., Torres-Lopez J.E., Granados-Soto V. Eur J Pharmacol., 2001, 418: 195
19. Hunter J.A., Blyth T.H. Drug Safety., 1999, 21: 353
20. Feixas J., Giovannoni M.P., Vergelli C., Gavaldà A., Cesari N., Graziano A., Dal Piaz V.  Bioorg. Med. Chem. Lett., 2005, 15: 2381
21. Dal Piaz V., Giovannoni M.P., Castellana C., Palacios J.M., Beleta J., Domenech T., Segarra V.  J. Med. Chem., 1997, 40: 1417
22. Ochiai K., Takita S., Kojima A., Eiraku T., Iwase K., Kishi T., Ohinata A., Yageta Y., Yasue T., Adams D.R., Kohno Y. Bioorg. Med. Chem. Lett., 2013, 23:375
23. Ochiai K., Takita S., Eiraku T., Kojima A., Iwase K., Kishi T., Fukuchi K., Yasue T., Adams D.R., Allcock R.W., Jiang Z., Kohno Y. Bioorg. Med. Chem., 2012, 20: 1644
24. Ochiai K., Ando N., Iwase K., Kishi T., Fukuchi K., Ohinata A., Zushi H., Yasue T., Adams D.R., Kohno Y. Bioorg. Med. Chem. Lett., 2011, 21: 5451
25. Van der Mey M., Bommelé K.M., Boss H., Hatzelmann A., Van Slingerland M., Sterk G.J., Timmerman H.J. Med. Chem., 2003, 46: 2008
26. Doherty A.M. Curr. Opin. Chem. Biol., 1999, 3, 466
27. Taiwo Y.O., Levine J.D. J. Neurosci., 1991, 11: 928
28. Kress M., Rodl J., Reeh P.W. Neurosci, 1996, 74:609
29. Sluka K.A. British J. Pharmacol., 1997, 122: 1165
30. Francischi J.N., Yokoro C.M., Poole S., Tafuri W.L., Cunha F.Q., Teixeira M.M. Eur. J. Pharmacol., 2000, 399: 243
31. Duarte I.D., Ferreira S.H. Mediators of Inflammation., 2000, 9: 25
32. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. Neurosci., 1994, 60: 347
33. Sakurada C., Sugiyama A., Nakayama M., Yonezawa A., Sakurada S., TanNo K., Kisara K., Sacurada T. Neurochem Inter., 2001, 38: 417
34. Machelska H., Przewlocki R., Radomski M.W., Przewlocka B. Polish J. Pharmacol., 1998, 50: 407
35. Hoheisel U., Unger T., Mense S. Pain., 2005, 117: 358
36. Torres-López J.E., Granados-Soto V. Eur. J. Pharmacol., 2005, 519: 75
37. Fleischhacker W.W., Hinterhuber H., Bauer H., Pflug B., Berner P., Simhandl C., Wolf R., Gerlach W., Jaklitsch H., Sastre-y-Hernandez M., Schmeding-Wiegel H.,Neuropsychobiol., 1992, 26: 59
38. Robichaud A., Tattersall F.D., Choudhury I., Rodger I.W. Neuropharmacol., 1999, 38: 289
39. Silvestre J.S., Fernandez A.G., Palacios J.M. Pharmacol. Biochem. Behav., 1999, 64: 1
40. Asif M. Curr. Med. Chem., 2012, 19: 2984